| Name | tert-butyl 4-(2-aminoethyl)piperazine-1-carboxylate |
|---|---|
| Synonyms |
MFCD02683049
1-(2-Aminoethyl)-4-boc-piperazine 4-(2-aminoethyl)piperazine-1-carboxylic acid tert-butyl ester 4-(2-Amino-ethyl)-1-Boc-piperazine 1- tert-Butoxycbonyl-4-(2-aminoethyl)piperazine 4-(2-AMINO-ETHYL)-PIPERAZINE-1-CBOXYLIC ACID TERT-BUTYL ESTER tert-Butyl 4-(2-aminoethyl)piperazin-1-cboxylate 4-(2-Amino-Ethyl)-Piperazine-1-Carboxylic Acid Tert-Butyl Ester 4-(tert-Butoxycbonyl)-1-(2-aminoethyl)piperazine TERT-BUTYL 4-(2-AMINOETHYL)PIPERAZINE-1-CBOXYLATE tert-Butyl-4-(2-aminoethyl)p tert-butyl 4-(2-aminoethyl)-1-piperazinecarboxylate 1-Piperazinecboxylic acid, 4-(2-aminoethyl)-, 1,1-dimethylethyl ester 4-(2-Amino-ethyl)-piperazine-1-cboxylic acid tert butyl es 1-(2-Aminoethyl)-4-tert-butoxycbonylpiperazine CHEMBRDG-BB 1-BOC-4-(2-AMINOETHYL)PIPERAZINE 4-(2-Amino-ethyl)-1-Boc-piperazin 4-(2-Aminoethyl)piperazine-1-cboxylicacidtert-butylester 1-Boc-4-(2-aminoethyl)piperazine 4-N-(2-Aminoethyl)-1-N-Bo 1-(2-aminoethyl)-4-Boc piperazine 1-(2-AMMONIOETHYL)-4-(TERT-BUTOXYCBONYL)PIPERAZIN-1-IUM 4-(2-AMINOETHYL)PIPERAZINE, N1-BOC PROTECTED 4-(2-aminoethyl)piperazine,n1-boc protected 1-(2-aminoethyl)-4-tert-butoxycarbonylpiperazine 1-(2-aminoethyl)-4-(t-butoxycarbonyl)piperazine 4-(2-Aminoethyl)-1-boc-piperazine 4-(2-Aminoethyl)-1-(tert-butoxycbonyl)piperazine 1-tert-butyloxycarbonyl-4-(2-aminoethyl)piperazine 4-(2-Aminoethyl)-1-(tert-butoxycbonyl)piperazine, tert-Butyl 4-(2-aminoethyl)piperazine-1-cboxylate 4-N-(2-Aminoethyl)-1-N-Boc-piperazine 4-N-(2-AMINOETHYL)-1-N-BOC-PIPERAZINE 4-(2-AMINO-ETHYL)-1-BOC-PIPERAZINE tert-butyl 4-(2-aminoethyl)piperazine-1-cboxylate(SALTDATA: FREE) BUTTPK 90 4-(2-AMINO-ETHYL)-PIPERAZINE-1-CBOXYLIC ACID TERT-BUTYL ESTER 192-0 1,1-Dimethylethyl-4-(2-aminoethyl)piperazine-1-cboxylate TERT-BUTYL 4-(2-AMINOETHYL)TETRAHYDRO-1(2H)-PYRAZINECBOXYLATE |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 319.4±32.0 °C at 760 mmHg |
| Molecular Formula | C11H23N3O2 |
| Molecular Weight | 229.319 |
| Flash Point | 147.0±25.1 °C |
| Exact Mass | 229.179031 |
| PSA | 58.80000 |
| LogP | 0.27 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.495 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36/37/39 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933599090 |
|
~25%
192130-34-0 |
| Literature: Aventis Pharma Deutschland GmbH Patent: US6395737 B1, 2002 ; |
|
~%
192130-34-0 |
| Literature: Heterocycles, , vol. 76, # 2 p. 1219 - 1235 |
|
~%
192130-34-0 |
| Literature: Bulletin of the Korean Chemical Society, , vol. 33, # 8 p. 2597 - 2602 |
|
~%
192130-34-0 |
| Literature: ChemMedChem, , vol. 9, # 4 p. 752 - 761 |
|
~%
192130-34-0 |
| Literature: Bulletin of the Korean Chemical Society, , vol. 33, # 8 p. 2597 - 2602 |
|
~%
192130-34-0 |
| Literature: Organic Process Research and Development, , vol. 9, # 1 p. 102 - 104 |
|
~%
192130-34-0 |
| Literature: Bulletin of the Korean Chemical Society, , vol. 33, # 8 p. 2597 - 2602 |
|
~%
192130-34-0 |
| Literature: ChemMedChem, , vol. 9, # 4 p. 752 - 761 |
| Precursor 6 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |